PMID: 1200526Dec 1, 1975Paper

Deficiency of the second component of complement (C2) with chronic vasculitis

Annals of Internal Medicine
P FriendA F Michael

Abstract

A patient had complete deficiency of the second component of complement associated with chronic vasculitis and increased susceptibility to infection. We discuss here results of the complement profile, histocompatibility typing, and studies of the functional properties of patient plasma or serum in chemotaxis and opsonization in relation to the disease entity and host susceptibility to infection.

Citations

Jun 1, 1978·Arthritis and Rheumatism·P H Schur
Jan 1, 1982·Journal of Clinical Immunology·H A SampsonP J Baker
Sep 1, 1978·The Journal of Experimental Medicine·C NerlG Valet
Oct 1, 1976·The Journal of Clinical Investigation·D GlassP H Schur
Dec 1, 1977·International Journal of Dermatology·T L Ray, K D Wuepper
Mar 1, 1978·International Journal of Dermatology·J P CallenJ J Voorhees
May 1, 1982·International Journal of Dermatology·G Tappeiner
Mar 1, 1981·Immunogenetics·D D RaumC A Alper
Aug 1, 1995·Annals of Medicine·M L Lokki, H R Colten
Jan 1, 1985·La Revue de médecine interne·M S DoutreJ J Regaudie
Nov 1, 1979·Seminars in Arthritis and Rheumatism·S R Stewart, M E Gershwin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.